Cargando…

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy

BACKGROUND: Adjuvant radiotherapy (RT) is one of the most commonly used treatments for de novo high-grade meningiomas (HGMs) after surgery, but genetic determinants of clinical benefit are poorly characterized. OBJECTIVE: We describe efforts to integrate clinical genomics to discover predictive biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jiaojiao, Sun, Shuchen, Chen, Jiawei, Wang, Daijun, Cheng, Haixia, Chen, Hong, Xie, Qing, Hua, Lingyang, Gong, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586415/ https://www.ncbi.nlm.nih.gov/pubmed/34778063 http://dx.doi.org/10.3389/fonc.2021.747592

Ejemplares similares

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
por: Sun, Shuchen, et al.
Publicado: (2022)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

m(6)A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes
por: Chen, Jiawei, et al.
Publicado: (2021)

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
por: Zhu, Hongda, et al.
Publicado: (2019)

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway
por: Ding, Yaodong, et al.
Publicado: (2022)

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)

The Diagnostic Value Of Using (18)F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
por: Hua, Lingyang, et al.
Publicado: (2019)

Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study
por: Byun, Hwa Kyung, et al.
Publicado: (2022)

Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study
por: Song, Dengpan, et al.
Publicado: (2021)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

Effectiveness of Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients After Gross Total Resection: A Meta-Analysis Study
por: He, Lingzhe, et al.
Publicado: (2021)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
por: Juratli, Tareq A., et al.
Publicado: (2017)

TERT promoter mutations in primary and secondary WHO grade III meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2020)

Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Specific gene expression signatures of low grade meningiomas
por: Tsitsikov, Erdyni N., et al.
Publicado: (2023)

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023)

Patterns of Care and Outcomes of Adjuvant Radiotherapy for Meningiomas: A Surveillance, Epidemiology, and End Results and Medicare Linked Analysis
por: Amsbaugh, Mark, et al.
Publicado: (2016)

Radiomics-Based Prediction of TERT Promotor Mutations in Intracranial High-Grade Meningiomas
por: Akkurt, Burak Han, et al.
Publicado: (2023)

Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy
por: Golub, Danielle, et al.
Publicado: (2019)

The Role of Adjuvant Treatment in Patients with High-Grade Meningioma
por: Cho, Minjae, et al.
Publicado: (2017)

Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas
por: Tian, Weidong, et al.
Publicado: (2020)

Intracranial Grade II Meningioma Oligometastatic to the Cervical Spine
por: Natarajan, Jyotsna M, et al.
Publicado: (2021)

Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020)

Effectiveness of Postoperative Radiotherapy on Atypical Meningioma Patients: A Population-Based Study
por: Zeng, Qiang, et al.
Publicado: (2019)

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

Predicting the grade of meningiomas by clinical–radiological features: A comparison of precontrast and postcontrast MRI
por: Yao, Yuan, et al.
Publicado: (2022)

The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis
por: Li, Jie-yun, et al.
Publicado: (2021)

Adjuvant Radiotherapy Improved Survival in Stage I to II Low-Grade Endometrial Stromal Sarcoma: A Retrospective Study of 152 Cases
por: Wang, Wenhui, et al.
Publicado: (2021)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
por: Kannapadi, Nivedha V., et al.
Publicado: (2022)

Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing
por: Kim, Junhyung, et al.
Publicado: (2022)

Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
por: Wang, Xuanchun, et al.
Publicado: (2012)

Radiation Boost After Adjuvant Whole Breast Radiotherapy: Does Evidence Support Practice for Close Margin and Altered Fractionation?
por: Gulstene, Stephanie, et al.
Publicado: (2020)

The Patient’s Perspective on Proton Radiotherapy of Skull Base Meningioma: A Retrospective Cross-Sectional Survey
por: Seidensaal, Katharina, et al.
Publicado: (2022)

Radiotherapy for meningiomas
por: Chen, William C., et al.
Publicado: (2022)

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
por: Haddad, Alexander F., et al.
Publicado: (2020)

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lkk6oe2r6tbtacjou3jjp2csgd